Archer-Daniels-Midland Co Clinical Trials
Studies registered on ClinicalTrials.gov (U.S. National Library of Medicine) with the company as lead sponsor or collaborator, newest start first. Values are as registered.
- 2026-10-01: Study NCT07830862; Company role Lead sponsor; Phase Not applicable; Status Not yet recruiting.
- 2026-06-01: Study NCT07594860; Company role Lead sponsor; Phase Not applicable; Status Not yet recruiting.
- 2025-05-29: Study NCT06710392; Company role Lead sponsor; Phase Not applicable; Status Terminated.
- 2025-02-01: Study NCT06795425; Company role Collaborator; Phase Not applicable; Status Not yet recruiting.
| Start date | Study | Company role | Phase | Status | Conditions | Enrollment | Completion date |
|---|---|---|---|---|---|---|---|
| 2026-10-01 | NCT07830862 The Effect of a Postbiotic on Oral Health in Healthy Adults | Lead sponsor | Not applicable | Not yet recruiting | Healthy | 56 | 2027-06-01 |
| 2026-06-01 | NCT07594860 Effect of a Probiotic or Postbiotic on Gut Microbiome During Antibiotic Treatment | Lead sponsor | Not applicable | Not yet recruiting | Microbiome | 126 | 2027-05-31 |
| 2025-05-29 | NCT06710392 Efficacy of Two Enzyme Cocktails in Healthy Adults | Lead sponsor | Not applicable | Terminated | Digestive; Gastrointestinal Health | 18 | 2026-02-28 |
| 2025-02-01 | NCT06795425 A Randomized, Double-Blind Study to Assess the Effect of a Postbiotic on Oxidative Stress and Exercise Performance | Collaborator Lead: Lindenwood University | Not applicable | Not yet recruiting | Oxidative Stress; Healthy; Exercise-induced Muscle Damage; Exercise-induced Muscle Soreness; Immune Function; Gut Health; Microbiome Analysis; Exercise Performance; Exercise Metabolism | 80 | 2026-01-01 |
| 2024-12-02 | NCT06701604 Changes in Amino Acid Absorption After Adding a Probiotic to an Acute Protein Feeding | Lead sponsor | Not applicable | Not yet recruiting | Amino Acid Absorption; Probiotic | 30 | 2026-01-15 |
| 2024-10-15 | NCT06480604 Effect of a Multi-strain Probiotic on Recurrent Vulvovaginal Candidiasis | Lead sponsor | Not applicable | Recruiting | Vulvovaginal Candidiasis | 126 | 2025-07 |
| 2024-06 | NCT06466174 Determination of the Safety and Efficacy of Two Probiotic Strains | Lead sponsor | Not applicable | Unknown | Gastrointestinal Dysfunction | 100 | 2026-05 |
| 2024-01-04 | NCT05562739 Pilot Study to Assess the Effect of a Postbiotic Blend on Moderate Self-reported Anxiety | Lead sponsor | Not applicable | Completed | Anxiety | 10 | 2024-02-28 |
| 2023-10-27 | NCT06103994 Study to Assess the Effect of Multistrain Probiotic on the Immune Response to the Influenza Vaccination | Lead sponsor | Not applicable | Completed | Influenza | 120 | 2024-01-12 |
| 2023-10-27 | NCT06047145 Evaluation of Soy Isoflavones on Skin Ageing Parameters | Lead sponsor | Not applicable | Completed | Skin Ageing | 66 | 2024-02-26 |
| 2023-10-19 | NCT06083311 The Efficacy of a Probiotic for Functional Constipation (FC) | Lead sponsor | Not applicable | Completed | Functional Constipation | 55 | 2024-12-17 |
| 2023-06-06 | NCT05754177 Safety and Efficacy of a Probiotic Supplement in IBS-D | Lead sponsor | Not applicable | Completed | Irritable Bowel Syndrome With Diarrhea; Irritable Bowel Syndrome | 46 | 2024-12-30 |
| 2023-05-09 | NCT05845073 The Efficacy of a Probiotic for Antibiotic Associated Gastrointestinal Symptoms | Lead sponsor | Not applicable | Completed | Antibiotic-associated Diarrhea | 69 | 2024-07-25 |
| 2023-03-20 | NCT05690373 Probiotics and Influenza Vaccination Response | Lead sponsor | Not applicable | Completed | Vaccine Response | 100 | 2023-06-30 |
| 2023-01-30 | NCT05577065 A Study to Assess the Effect of a Probiotic on Upper Respiratory Tract Infections in Healthy Children | Lead sponsor | Not applicable | Completed | Upper Respiratory Tract Infections; Upper Resp Tract Infection | 200 | 2024-03-13 |
| 2022-12-20 | NCT05562752 Pilot Study to Assess the Effect of a Probiotic Blend on Moderate Self-reported Anxiety. | Lead sponsor | Not applicable | Completed | Anxiety | 100 | 2023-08-15 |
| 2022-09-30 | NCT05432479 Study to Evaluate the Efficacy of a Probiotic in Infantile Colic Symptoms Relief | Lead sponsor | Not applicable | Completed | Infantile Colic | 101 | 2026-04-15 |
| 2022-07-01 | NCT05440630 Study of Efficacy of a Probiotic and Postbiotic in Overweight and Obese Individuals | Lead sponsor | Not applicable | Withdrawn | Obesity | 0 | 2023-10-30 |
| 2022-07-01 | NCT05428137 Study of Safety and Efficacy of a Probiotic and Postbiotic in Overweight Individuals | Lead sponsor | Not applicable | Unknown | Obesity; Abdominal Obesity | 180 | 2024-12 |
| 2021-10-01 | NCT05750433 Phage 3Determination of Phage/Probiotic Synergistic Effects on Gastrointestinal Health | Collaborator Lead: Colorado State University | Not applicable | Completed | Gastrointestinal Dysfunction | 120 | 2024-03-31 |
| 2020-10-19 | NCT04489810 Digestion of Gluten in the Presence of Enzymes | Lead sponsor | Not applicable | Completed | Main Focus: Gluten and Starch Digestibility | 11 | 2021-04-08 |
| 2008-11 | NCT01305291 Fibersol-2 Clinical Trials Related to Appetite | Collaborator Lead: Iowa State University | Not applicable | Completed | Lack of Satiety | 20 | 2009-11 |
| 2007-12 | NCT01314586 Flax Lignans and Heart Health | Collaborator Lead: Iowa State University | Not applicable | Completed | Hypercholesterolemia | 93 | 2009-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bunge Global SA (BG) | Switzerland | $21.391B | 36.03 |
| DARLING INGREDIENTS INC. (DAR) | United States | $9.740B | 15.03 |